BioCardia, Inc.
BCDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,982 | $14,064 | $111,073 | $98,474 |
| - Cash | $2,371 | $1,103 | $7,363 | $12,872 |
| + Debt | $951 | $1,315 | $1,631 | $1,868 |
| Enterprise Value | $4,562 | $14,276 | $105,341 | $87,470 |
| Revenue | $58 | $477 | $1,352 | $1,015 |
| % Growth | -87.8% | -64.7% | 33.2% | – |
| Gross Profit | -$4,329 | -$7,249 | -$7,482 | $375 |
| % Margin | -7,463.8% | -1,519.7% | -553.4% | 36.9% |
| EBITDA | -$7,934 | -$11,560 | -$11,819 | -$12,570 |
| % Margin | -13,679.3% | -2,423.5% | -874.2% | -1,238.4% |
| Net Income | -$7,946 | -$11,571 | -$11,907 | -$12,621 |
| % Margin | -13,700% | -2,425.8% | -880.7% | -1,243.4% |
| EPS Diluted | -2.9 | -8.19 | -10.05 | -11.19 |
| % Growth | 64.6% | 18.5% | 10.2% | – |
| Operating Cash Flow | -$8,026 | -$9,974 | -$10,561 | -$10,366 |
| Capital Expenditures | -$6 | -$12 | -$70 | -$116 |
| Free Cash Flow | -$8,032 | -$9,986 | -$10,631 | -$10,482 |